MedeAnalytics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MedeAnalytics, Inc. - overview
Established
1994
Location
Richardson, TX, US
Primary Industry
Software
About
MedeAnalytics, Inc. is a US-based healthcare analytics company that provides advanced data management solutions to enhance patient care and optimize financial outcomes across the healthcare sector. Founded in 1994 and headquartered in Richardson, US, MedeAnalytics specializes in healthcare data analytics. The company underwent a Secondary Buyout in September 2020 when JLL Partners acquired it from Thoma Bravo for approximately USD 250.
00 mn. The firm has completed a total of 4 deals since its inception, with the latest deal occurring on September 29, 2020. The current CEOs are Paul Kaiser and Steve Grieco. MedeAnalytics offers a comprehensive suite of healthcare data management and analytics solutions designed to enhance patient care and optimize financial outcomes.
The company's core products include Health Fabric™, a proprietary technology for seamless data integration across healthcare platforms, and Managed Action™, which provides actionable insights for improved organizational performance. AI Studio leverages advanced artificial intelligence and machine learning for predictive analytics, while Integrated Analytics combines clinical, financial, and operational data to support value-based care delivery. The company serves a diverse clientele, including healthcare providers, payers, and employers in the US and beyond. MedeAnalytics generates revenue primarily through a subscription-based model for its software-as-a-service (SaaS) offerings.
Clients typically engage in multi-year contracts, providing access to key products such as Health Fabric™ and Managed Action™. Revenue transactions are structured in a B2B manner, ensuring customized pricing plans based on client needs, ultimately aiming to drive improvements in cost efficiency and patient outcomes. MedeAnalytics intends to leverage its recent funding from the Secondary Buyout in September 2020 to enhance its product offerings and expand into new markets. The company is focused on developing additional functionalities within its existing products, with plans for new releases in the coming year.
Additionally, MedeAnalytics aims to penetrate international markets, targeting expansion efforts in Europe and Asia by 2023. The funding will support these initiatives, enhancing product development and market outreach.
Current Investors
JLL Partners, Emergence Capital, Industry Ventures
Primary Industry
Software
Sub Industries
Healthcare IT, Web Applications, Accounting/Finance Software, Analytics & Performance Software, Application Integration Software
Website
www.medeanalytics.com
Verticals
Cloud Computing, Cloud Computing, HealthTech
Company Stage
Mature
Total Amount Raised
Subscriber access only
MedeAnalytics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | SubPop Health, Inc. | - | ||||||||
| Secondary Buyout | Completed | MedeAnalytics, Inc. | - | ||||||||
| Secondary Buyout | Completed | MedeAnalytics, Inc. | - |
Displaying 1 - 3 of 3
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.